Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	33.49B +36.2%
Revenue (ttm)	5.53B +43.2%
Net Income	1.02B +79.3%
EPS	22.43 +40.3%
Shares Out	46.05M
PE Ratio	32.42
Forward PE	24.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157,947
Average Volume	159,497
Open	740.00
Previous Close	736.55
Day's Range	715.00 - 740.00
52-Week Range	440.30 - 876.50
Beta	n/a
RSI	34.59
Earnings Date	May 30, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 194
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In fiscal year 2025, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.